Milestone Scientific Inc. (MLSS) Bundle
A Brief History of Milestone Scientific Inc. (MLSS)
Company Formation and Early Developments
Company Formation and Early Developments
Milestone Scientific Inc. was founded in 1997. The company specializes in developing and commercializing innovative injection technology for the healthcare sector. The first significant product was the CompuFlo® Epidural System, introduced in the early 2000s, which revolutionized epidural anesthesia.
Public Offering and Market Presence
Milestone Scientific went public in 1998, trading on the American Stock Exchange under the ticker symbol MLSS. As of 2023, Milestone Scientific transitioned its listing to the NYSE American exchange. The company has been focused on expanding its market presence and product offerings.
Financial Performance
| Year | Revenue ($ million) | Net Income ($ million) | Stock Price ($) |
|---|---|---|---|
| 2019 | 3.5 | -1.1 | 0.40 |
| 2020 | 4.1 | -0.8 | 0.45 |
| 2021 | 5.6 | -0.5 | 0.60 |
| 2022 | 6.9 | -0.2 | 0.75 |
| 2023 (estimated) | 8.2 | 0.1 | 1.00 |
Strategic Partnerships and Acquisitions
In 2021, Milestone Scientific entered into a strategic partnership with major healthcare distributors to enhance the distribution of its products. The company also acquired several patents related to its technology, further solidifying its intellectual property portfolio.
Product Innovations
Milestone Scientific's product line includes:
- CompuFlo® Epidural System
- Wand® Dental Injection System
- Digital Anesthesia Technology
In 2023, the company announced the launch of a new wireless version of the CompuFlo® system, improving the ease of use in clinical settings.
Market Opportunities and Challenges
Milestone Scientific operates in a competitive medical device market, valued at approximately $450 billion in 2022. The company faces challenges from larger competitors but has opportunities in expanding its innovative technologies into new markets.
Recent Developments
As of October 2023, Milestone Scientific has reported a growth trajectory, with a focus on expanding its international sales and presence in Europe and Asia. The company's ongoing clinical trials and product enhancements aim to capture broader market share.
Stock Performance
The stock performance of Milestone Scientific has shown a significant increase within the past year, reflecting an uptick in market confidence:
| Date | Stock Price ($) | Market Capitalization ($ million) |
|---|---|---|
| January 2022 | 0.75 | 37.5 |
| April 2022 | 0.85 | 42.5 |
| July 2022 | 0.90 | 45.0 |
| January 2023 | 0.95 | 47.5 |
| October 2023 | 1.00 | 50.0 |
A Who Owns Milestone Scientific Inc. (MLSS)
Shareholder Structure
Shareholder Structure
Milestone Scientific Inc. (MLSS) has a diverse shareholder base comprising institutional and individual investors. As of the latest financial reports, the following table outlines the major shareholders and their respective ownership percentages:
| Shareholder | Ownership Percentage | Number of Shares |
|---|---|---|
| Renaissance Technologies LLC | 5.98% | 1,180,000 |
| BlackRock Inc. | 4.70% | 925,000 |
| The Vanguard Group, Inc. | 3.90% | 780,000 |
| Management and Insiders | 16.25% | 3,200,000 |
| Other Institutional Investors | 20.00% | 4,000,000 |
| Retail Investors | 49.17% | 9,834,000 |
Market Capitalization
As of the latest available data in October 2023, Milestone Scientific Inc. had a market capitalization of approximately $50 million.
Stock Performance
The stock performance of MLSS has shown variations influenced by market conditions. The following key financial metrics reflect its recent performance:
| Metric | Value |
|---|---|
| Current Stock Price | $2.50 |
| 52-Week High | $4.00 |
| 52-Week Low | $1.80 |
| Volume | 300,000 shares |
Recent Financial Results
Milestone Scientific reported the following key financial results for the fiscal year ending December 31, 2022:
| Financial Metric | Value |
|---|---|
| Total Revenue | $6.1 million |
| Net Income | -$2.0 million |
| Total Assets | $10.5 million |
| Total Liabilities | $4.5 million |
Insider Ownership
As of the latest filings, the management team and board of directors hold a significant portion of shares, underlining their commitment to the company:
| Name | Position | Ownership Percentage |
|---|---|---|
| Leonard Osser | CEO | 7.00% |
| Mary V. Ann | COO | 5.00% |
| Michael Peach | CFO | 4.00% |
Institutional Investor Interests
Institutional investors have shown continued interest in MLSS. The following table details the changes in institutional ownership over the last fiscal year:
| Investor | Change in Ownership (%) |
|---|---|
| Renaissance Technologies LLC | +1.5% |
| BlackRock Inc. | +0.6% |
| Vanguard Group | -0.2% |
Milestone Scientific Inc. (MLSS) Mission Statement
Company Vision
Milestone Scientific Inc. aims to enhance the quality of patient care through innovation in medical technologies. The company focuses on developing and commercializing proprietary instrument delivery systems for dental and medical markets.
Core Values
- Innovation: Commitment to advancing technology in the medical field.
- Quality: Ensuring the highest standards in product development and delivery.
- Integrity: Upholding ethical practices in business operations.
- Collaboration: Partnering with healthcare professionals to improve treatment outcomes.
Financial Performance
As of the latest fiscal year, Milestone Scientific reported the following financial figures:
| Fiscal Year | Revenue ($ million) | Net Income ($ million) | Total Assets ($ million) | Market Capitalization ($ million) |
|---|---|---|---|---|
| 2022 | 5.2 | 1.1 | 10.6 | 45.5 |
| 2023 (Q2) | 3.0 | 0.5 | 12.2 | 48.0 |
Product Offerings
Milestone Scientific's flagship products include:
- Wand®: A computer-controlled anesthetic delivery system used in dentistry.
- CompuFlo®: A pain management system designed for various medical procedures.
- Other Medical Devices: Focused on enhancing precision in injections and procedures.
Market Reach
The company distributes its products in over 30 countries worldwide, targeting both urban and rural healthcare facilities.
Strategic Partnerships
Milestone Scientific collaborates with various healthcare institutions and distributors to expand its reach and enhance product development.
Research and Development Investment
In the fiscal year of 2022, Milestone Scientific allocated approximately $1.2 million to research and development to promote innovation and product enhancement.
Future Aspirations
The company aims to broaden its product portfolio and increase its presence in emerging markets, with specific targets set for the next 5 years:
| Year | Projected Revenue Growth (%) | New Product Launches | Target Markets |
|---|---|---|---|
| 2024 | 15% | 2 | Asia, Latin America |
| 2025 | 20% | 3 | Africa, Europe |
| 2026 | 25% | 4 | North America expansion |
Commitment to Sustainability
Milestone Scientific is dedicated to implementing sustainable practices in its operations, focusing on environmentally friendly materials and reducing waste in manufacturing processes.
How Milestone Scientific Inc. (MLSS) Works
Company Overview
Milestone Scientific Inc. (MLSS) is a biotechnology company focused on innovative injection technology. The company's primary goal is to enhance patient comfort and outcomes in the dental and medical fields through its patented technology.
Revenue and Financial Performance
As of Q2 2023, Milestone Scientific reported revenues of approximately $2.3 million for the quarter, an increase compared to $1.5 million in the second quarter of 2022. The company has been experiencing growth in its sales due to increased adoption of its technologies.
The following table summarizes key financial data for Milestone Scientific Inc. for the fiscal year 2022:
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Total Revenue | $8.5 million | $5.0 million |
| Net Income | $(3.1 million) | $(4.5 million) |
| Cash and Cash Equivalents | $5.2 million | $1.0 million |
| Total Assets | $9.9 million | $5.2 million |
| Operating Expenses | $6.8 million | $5.6 million |
Technology Overview
Milestone Scientific specializes in the development of computer-controlled local anesthetic delivery systems. Their flagship product, the CompuFlo® system, uses a pressure-sensing technology that allows for real-time monitoring of fluid delivery. This technology aims to minimize pain perception during injections.
Market Applications
- Dentistry
- Obstetrics
- Outpatient Surgery
- Pain Management
Market Penetration and Distribution
As of 2023, Milestone Scientific operates in over 30 countries and has established partnerships with multiple distributors to enhance market accessibility. The company aims to increase its distribution network to expand its global footprint.
Recent Developments
In August 2023, Milestone Scientific announced a collaboration with a major dental supply company to enhance distribution efficiency. This partnership is expected to increase sales by 25% year-over-year according to management projections.
Stock Performance
As of October 2023, the stock price of Milestone Scientific Inc. (MLSS) is trading at approximately $1.50 per share. The company's market capitalization stands at around $69 million.
The following table provides a snapshot of Milestone Scientific's stock performance over the past year:
| Metric | Current Price | 52-Week High | 52-Week Low |
|---|---|---|---|
| MLSS Stock Price | $1.50 | $2.35 | $0.80 |
| Market Cap | $69 million | ||
| Volume (30-Day Avg) | 250,000 shares |
Challenges and Opportunities
Milestone Scientific faces challenges, including competition from established players in the medical device sector and regulatory hurdles. However, the increasing demand for minimally invasive procedures presents significant growth opportunities.
Conclusion of Milestone Scientific Inc. Operations
Milestone Scientific continues to innovate and expand its market presence through strategic partnerships and technological advancements. The company is committed to improving patient outcomes and enhancing the delivery of healthcare services.
How Milestone Scientific Inc. (MLSS) Makes Money
Product Sales
Milestone Scientific Inc. generates a significant portion of its revenue through the sale of its proprietary medical instruments and devices. The company’s primary product lines include:
- Computer-controlled Anesthesia Delivery Systems
- Dental Instruments
As of 2022, Milestone Scientific reported product sales of approximately $4.1 million, which represented a 30% increase from the previous year.
Service Agreements and Recurring Revenue
Milestone Scientific also establishes service agreements aimed at maintaining the instruments sold to healthcare providers. These agreements often include:
- Annual maintenance and support
- Training for healthcare professionals
In the fiscal year 2022, recurring revenue from service agreements accounted for about $1.2 million, reflecting a growth of 25% compared to 2021.
Research and Development Partnerships
The company collaborates with several academic institutions and commercial enterprises to innovate new applications for its technology. Such partnerships often bring additional revenue through:
- Grants
- Joint ventures
In 2022, Milestone Scientific secured approximately $300,000 in grant funding from various institutions for ongoing R&D projects.
Market Expansion Efforts
Milestone Scientific focuses on expanding its market presence both geographically and through diversified applications. The company launched its products in various international markets, including:
- Canada
- Europe
- Asia
In 2022, the expansion efforts contributed to a revenue increase of $1 million from international sales, a 40% rise from 2021 figures.
Financial Performance Overview
The financial performance of Milestone Scientific has shown promising trends, as indicated in the following table:
| Fiscal Year | Total Revenue ($M) | Product Sales ($M) | Service Revenue ($M) | Net Income ($M) |
|---|---|---|---|---|
| 2022 | 5.3 | 4.1 | 1.2 | 0.5 |
| 2021 | 4.0 | 3.2 | 0.96 | (0.3) |
| 2020 | 3.5 | 2.8 | 0.7 | (0.4) |
As shown, the company successfully transitioned from a net loss in 2020 and 2021 to achieving a net income of $0.5 million in 2022.
Strategic Acquisitions
Milestone Scientific has engaged in strategic acquisitions to enhance its product offerings and market reach. Key acquisitions include:
- Acquisition of technology assets for dental applications in early 2021
- Purchase of a medical device company focused on anesthetic delivery
These acquisitions contributed an estimated $1 million in additional revenue in 2022.
Market Trends and Projections
The medical device market, especially in anesthesia and dental applications, is projected to grow significantly. According to industry reports, the global anesthesia equipment market is expected to reach $8.5 billion by 2026, with a CAGR of around 5% from 2021.
Such market trends indicate strong potential for Milestone Scientific’s continued growth and profitability in the coming years.
Milestone Scientific Inc. (MLSS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support